Relevant Publications

  1. Rantapää Dahlqvist S, Wållberg Jonsson S, Dahlén G : Lipoprotein(a), lipids and apolipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis 1991; 50: 366-368*
  2. Nilsson TK, Norberg B, Wållberg Jonsson S, Rantapää Dahlqvist S. Von Willebrand factor in plasma as risk indicator for cardiovascular events. Letter. J Intern Med 1991; 229: 557-560.
  3. Wållberg Jonsson S, Dahlén G, Nilsson T K, Rånby M, Rantapää Dahlqvist S. Tissue plasminogen Activator, Plasminogen Activator Inhibitor-1 and von Willebrand Factor in Rheumatoid arthritis. Clinical Rheumatology, 1993;12:318-24
  4. Wållberg Jonsson S, Dahlén G, Uddhammar A, Rantapää Dahlqvist S. Lipoprotein (a) in relation to acute phase reaction in patients with rheumatid arthritis and polymyalgia rheumatica. Scand J Clin Lab Invest 1995; 55: 309-15
  5. Wållberg Jonsson S, Dahlén G, Johnson O, Olivecrona G, Rantapää- Dahlqvist S. Lipoprotein lipase in relation to inflammatory activity in rheumatoid arthritis. J Int Med 1996; 240: 373-80
  6. Wållberg Jonsson S, Öhman M-L, Rantapää Dahlqvist S. Cardiovascular mortality and morbidity in patients with seropositive rheumatoid arthritis in Northern Sweden.J Rheumatol 1997; 24: 445-51
  7. Wållberg Jonsson S, Johansson H, Öhman M-L, Rantapää Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. J Rheumatol 1999; 26: 2562-71
  8. Wållberg Jonsson S, Cederfeldt M, Rantapää Dahlqvist S. Hemostatic factors and cardiovascular disease in active rheumatoid arthritis-an eight year follow-up study. J Rheumatol 2000; 27; 71-5
  9. Wållberg Jonsson S, Lundström E, Backman C, Karp K, Rantapää Dahlqvist S. Incerased prevalence of atherosclerosis in patients with medium-therm rheumatoid arthritis.J Rheumatology 2001; 28: 2597-602
  10. Wållberg Jonsson S, Öhman M-L, Rantapää Dahlqvist S. Risk of cardiovascular events and effect on mortality in patients with rheumatoid arthritis. Letter. J Rheumatol 2000; 27: 2282
  11. Wållberg Jonsson S, Trifunovic J, Lefvert AK, Sundqvist KG, Rantapää Dahlqvist S. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J Rheumatology. 2002;29:875-82
  12. Wållberg Jonsson S, Rantapää Dahlqvist S, Öhman M-L. Which factors are related to the presence of atherosclerosis in rheumatoid arthritis. Scand J Rheumatol 2004; 33: 373-9*
  13. Wållberg Jonsson S, Rantapää Dahlqvist S. Reumatoid artrit – möjlig riskmarkör för kardiovaskulär sjukdom Läkartidningen 2004; 101:3672-5
  14. Sodergren A, Lundberg V, Stegmayr B, Öhman M-L, Wållberg Jonsson S. Increased incidence and impaired progosis after acute myocardial infarction among patients with rheumatoid arthritis. Ann Rheum Dis. 2007 Feb;66(2):263-6. Epub 2006 Jul 19.
  15. Ljung L, Olsson T, Engstrand S, Wållberg Jonsson S, Söderberg S, Rantapää Dahlqvist S. IL-1Ra is associated with both lipid metabolism and inflammation in rheumatoid arthritis. Clin Exp Rheumatol. 2007;25:617-20
  16. Ärlestig L, Wållberg Jonsson S, Rantapää Dahlqvist S. Polymorphism of genes relted to cardiovascular disease in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2007 Nov-Dec;25(6):866-71
  17. Wållberg-Jonsson S, Caidahl K, Klintland N, Nyberg G, Rantapää-Dahlqvist S. Increased arterial stiffness and indication of endothelial dysfunction in longstanding rheumatoid arthritis. Scand J Rheumatol. 2008 Jan-Feb;37(1):1-5
  18. Södergren A, Stegmayr B, Öhman M-L, Wållberg-Jonsson S. Increased incidence of, and impaired prognosis after, stroke among patients with seropositive rheumatoid arthritis. Clin Exp Rheumatol. 2009 Jul-Aug;27(4):641-4.
  19. Södergren A, Boman K, Eriksson C, Karp K, Lundström E, Smedby T, Söderlund L, Rantapää-Dahlqvist S, Wållberg-Jonsson S. Atherosclerosis in early Rheumatoid Arthritis: Very early Endothelial Activation and Rapid Progress of Intima Media Thickness. Arthritis Res Ther 2010; 12: R 158. Epub 2010 Aug 16
  20. Berglund S, Södergren A, Wållberg-Jonsson S, Rantapää-DahlqvistS Cardiovascular event in rheumatoid arthritis is predicted by homocysteine – a six- year follow-up study. Clin Exp Rheumatol. 2009 Sep-Oct;27(5):822-5
  21. Innala L, Möller Bozena, Ljung L, Magnusson S, Smedby S , Södergren A, Öhman Marie-Louise, Rantapää Dahlqvist S, Wållberg Jonsson S. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study Arthritis research & therapy 2011:13(4):R131
  22. Wållberg Jonsson S, Ljung L, Forsblad-dElia H, Henrohn D, TuressonC, Svenungsson E. Riktlinjer för kardiovaskulär prevention vid inflammatoriska reumatiska sjukdomar. Lakartidningen. 2012 Jan 11-17;109(1-2):27-9. Swedish.
  23. Holmqvist M, Neovius N, Eriksson J, Mantel Ä, Wållberg-Jonsson S, Jacobsson L, Askling J. Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization. JAMA. 2012;308(13):1350-1356. doi:10.1001/2012.jama.11741
  24. Holmqvist M, Gränsmark E, Mantel Ä, Alfredsson L, Jacobsson L, Wållberg-Jonsson S, Askling J.Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis. Ann Rheum Dis annrheumdis-2012-201387Published Online First: 18 May 2012
  25. Sundström B, Johansson G, Johansson I, Wållberg-Jonsson S. Diet and cardiovascular risk factors among patients with ankylosing spondylitis in comparison with the general population. Clin Rheumatol. 2014 Jan;33(1):111-7. doi: 10.1007/s10067-013-2410-4. Epub 2013 Oct 19
  26. Öhman M, Öhman M-L, Wållberg-Jonsson S. The apoB/apoA1 ratio predicts future cardiovascular events in patients with rheumatoid arthritis. Scand J Rheumatol. 2014 Apr 2. [Epub ahead of print]
  27. Sundström B, Johansson G, Johansson I, Wållberg-Jonsson S. Modifiable cardiovascular risk factors in patients with ankylosing spondylitis. Clin Rheumatol (2014) 33:111–117
  28. Hörnberg K, Ångström L, Wållberg-Jonsson S. Group cycling to affect cardiovascular risk factors in rheumatoid arthritis patients: feasibility and benefits. Submitted and revised for Cardiopulmonary physical therapy journal
  29. Svennungsson E, Gustafsson J, Leonard D, Sandling J, Gunnarsson I, Nordmark G, Jönsen A, Bengtsson AA, Sturfelt G, Rantapää-Dahlqvist S, Elvin K, Sundin U, Garnier S, Sigurdsson S, Padyukov L, Syvänen AC, Rönnblom L. A STAT4 risk allele is associated with ischemic cerebrovascular events and antiphospholipid antibodies in systemic lupus erythematosus. Ann Rheum Dis. 2010 May;69(5):834-40. Epub 2009 Sep 17.
  30. Holmqvist ME, Wedrén S, Jacobsson LT, Klareskog L, Nyberg F, Rantapää-Dahlqvist S, Alfredsson L, Askling J. Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J Intern Med. 2010 Aug 4. [Epub ahead of print]PMID: 20698926
  31. Bengtsson C, Öhman ML, Nived O, Rantapää Dahlqvist S. Cardiovascular event in Systemic Lupus Erythematosus in northern Sweden – Incidence and predictors in a 7-year follow up study. Lupus. 2012 Apr;21(4):452-9. doi: 10.1177/0961203311425524. Epub 2011 Nov 7
  32. Ljung L, Simard J, Jacobson L, Rantapää-Dahlqvist S, Askling J. Treatment with Tumour Necrosis Factor-inhibitors and the Risk of Acute Coronary Syndromes in Early Rheumatoid Arthritis. Arthritis Rheum. 2012 Jan;64(1):42-52. doi: 10.1002/art.30654.
  33. Ärlestig L, Rantapää-Dahlqvist S. Polymorphisms of the genes encoding CD40 and growth differentiation factor 15 and in the 9p21.3 region in patients with rheumatoid arthritis and cardiovascular disease. J Rheumatol. 2012 May;39(5):939-45. doi: 10.3899/jrheum.111336. Epub 2012 Apr 15.
  34. Leonard D, Svenungsson E, Sandling JK, Berggren O, Jönsen A, Bengtsson C, Wang C, Jensen-Urstad K, Granstam SO, Bengtsson AA, Gustafsson JT, Gunnarsson I, Rantapää-Dahlqvist S, Nordmark G, Eloranta ML, Syvänen AC, Rönnblom L. Coronary heart disease in systemic lupus erythematosus is associated with interferon regulatory factor-8 gene variants.Circ Cardiovasc Genet. 2013 Jun;6(3):255-63. doi: 10.1161/CIRCGENETICS.113.000044. Epub 2013 May 9.